Inspire is a social networking website that was created eight years ago to accelerate clinical trial recruitment. Inspire claims they can deliver patients, screened based on a protocol’s inclusion and exclusion criteria, because it has a pre-existing relationship with members who have volunteered to be trial participants.
Their first step was to build online communities around a particular disease, which Inspire has done in partnership with dozens of non-profit health associations. Trial recruitment began in 2008 and Inspire has four contracts in place, two with a major pharma for trials in osteoporosis, arthritis, and lung cancer.
To the delight of trial sponsors, Inspire offers a “quality assurance” service whereby trial participants are surveyed about their satisfaction with the investigative site. Responses get reported, in aggregate, to companies. Inspire owns and operates the communities which satisfies industry’s liability concerns regarding conversations about off-label use of their products and adverse events.
From time to time they provide Inspire members with information relevant to their health interests. Through Lung Cancer Profiles, they sent out a message on behalf of Pfizer Oncology and six lung cancer advocacy organizations who are working together to raise awareness of the role of molecular testing in lung cancer.
They are encouraging everyone fighting non-small cell lung cancer (NSCLC) to explore how molecular profiling could guide their treatment plans. They've provided a video, called A Different Approach to Non-small Cell Lung Cancer, to share with friends to help spread the word about molecular profiling.
http://www.lungcancerprofiles.com/mo...23|276317014|0